Stay updated with breaking news from Negotiation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As discussed throughout this Update, the implementation of the Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program")...
The Biden administration in a recent court filing forcefully pushed back on claims that the Medicare drug negotiation process is unconstitutional. Medicare’s ability to negotiate drug prices has plenty of legal precedent and manufacturers are not being forced to participate, the Biden administration said this week in response to a lawsuit from drugmaker Merck. According…
On Tuesday, August 29, 2023, the Centers for Medicare & Medicaid Services (CMS) released the first ten prescription drugs selected for price negotiation with manufacturers...
Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto. The lawsuit, filed in federal court in New Jersey, is the first since the Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to price negotiations by the Medicare health program, which covers 66 million people. Other drugs selected were Bristol Myers Squibb and Pfizer’s blood thinner Eliquis, Merck's diabetes drug Januvia, and Eliqu...
Today, the Centers for Medicare & Medicaid Services (CMS) released the first 10 drugs (“Listed Drugs”) that will be included in the Inflation Reduction Act’s Medicare Drug Price...